Seizures and Prolonged QTc with Atomoxetine Overdose [3]

American Journal of Psychiatry

Volumn 161, Issue 4, 2004, Pages 757-

  Sawant, Sharad ^a   Daviss, Steven R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; ATOMOXETINE; CHARCOAL; CYTOCHROME P450 2D6; DIAZEPAM; DRUG METABOLITE; FLUOXETINE; HYDROXYATOMOXETINE; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PHENYTOIN; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL EXPERIMENT; ATTENTION DEFICIT DISORDER; CASE REPORT; CONVULSION; DISEASE SEVERITY; DRUG OVERDOSE; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; HYPERACTIVITY; INGESTION; LETTER; MAJOR DEPRESSION; MALE; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; QT INTERVAL; SEIZURE;

EID: 1842532596     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.161.4.757     Document Type: Letter

References (3)

1. Strattera package insert. Eli Lilly, Nov 26, 2002
2. Wernicke JF, Kratochvil CJ: Safety profile of atomoxetine in the treatment of children and adolescents with ADHD. J Clin Psychiatry 2002; 63(suppl 12):50-55
3. Davidson J: Seizures and bupropion: a review. J Clin Psychiatry 1989; 50:256-261